钟芳芳, 张巍, 王成辉, et al. Comparison of clinicopathologic features of breast carcinoma in Shanghai Han and Xinjiang Uygur women[J]. China Oncology, 2014, 24(1): 21-28.
钟芳芳, 张巍, 王成辉, et al. Comparison of clinicopathologic features of breast carcinoma in Shanghai Han and Xinjiang Uygur women[J]. China Oncology, 2014, 24(1): 21-28. DOI: 10.3969/j.issn.1007-3969.2014.01.004.
Comparison of clinicopathologic features of breast carcinoma in Shanghai Han and Xinjiang Uygur women
Background and purpose: Breast cancer is a group of heterogeneous diseases which has racial disparities. Our study was to elucidate the clinicopathologic features of breast carcinoma in Shanghai Han and Xinjiang Uygur women and to analyze the racial differences. Methods: In this study
125 cases of breast invasive ductal carcinoma of Shanghai Han women and 85 cases of Xinjiang Uygur women were collected. The clinical stage was analyzed. Histological grading was observed. Immunohistochemical staining of ER
PR
HER-2
CK5/6
CK14
EGFR
Ki-67 was performed. Molecular subtypes were studied. Results: The average age of onset of breast cancer in Xinjiang Uygur women was younger than in Shanghai Han women (P0.05)
and Xinjiang Uygur women were more likely to be diagnosed at less than 35 years old (P0.01). The proportion of stageⅠwas higher in Shanghai Han women (20.0% vs 8.2%)
while the proportion of stage Ⅲ was higher in Xinjiang Uygur women (50.6% vs 27.2%) (P0.01). The proportion of grade 2 was higher in Shanghai Han women (67.2% vs 43.5%)
while the proportion of grade 3 was higher in Xinjiang Uygur women (47.1% vs 31.2%) (P0.01). The proportion of luminal A subtype was higher in Shanghai Han women (36.8% vs 18.3%)
while the proportion of basal-like subtype was higher in Xinjiang Uygur women (29.6% vs 12.0%) (P0.01). The molecular subtype was associated with race and histological grade (P0.05). Conclusion: There are racial differences in clinicopathologic features of breast carcinoma between Shanghai Han and Xinjiang Uygur women.
Receptor discordance between primary breast cancer and liver metastases
乳腺癌精准治疗的现状与展望
Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2026 edition)
Progress and prospects of CENPA-driven chromosomal instability in breast cancer: mechanisms, prognostic implications, and therapeutic perspectives
A study of 30-year trends in incidence and mortality risks of breast cancer among young women in China
Related Author
Yizi JIN
Mingxi LIN
Jian ZHANG
Precision treatment in breast cancer: current advancements
future directions WU Wei
ABUDUREHEIYIMU Nilupai
FAN Ying
The Society of Breast Cancer China Anti-Cancer Association
Related Institution
Phase Ⅰ Clinical Trial Center, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital& Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Department of Cancer Prevention, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University